Pharmacokinetics and pharmacodynamics, basic principles Flashcards
What is the definition of Pharmacokinetics?
Study of rate processes of absorption, distribution and biotransformation of drugs, poisons and other chemicals of both exogenous and endogenous origin
What is the concept of Therapeutic Window?
Low therapeutic index: Overlap of therapeutic range and toxic range.
- Drug Examples: lithium, theophylline, phenytoin, carbamazepine, digoxin, etc.
High therapeutic index: little or no overlap of therapeutic range and toxic range.
- Drug Examples: numerous such as antibiotic, analgesics, statins, etc
What is the clinical value of knowing drug specific levels?
- Unnecessary when dosage need not be individualised.
- Unnecessary when drug effect can be clinically observed.
- Useless when serum concentration is not related to pharmacological effect.
- Not yet useful when concentration-effect relationship is not defined – new drugs?
- Useful when therapeutic range of serum concentration has been established – this can be debated
Why do we request drug levels?
- Therapeutic confirmation
- Suspected toxicity
- Absence of therapeutic response: Drug failure, Non-compliance, Altered clearance, Altered absorption
- Drug Overdose
- Poor dose-response correlation
- Monitoring active metabolites
- Suspected drug interactions
What are factors involved in Pharmacokinetics?
- Absorption
- Distribution
- Metabolism
- Excretion
What are factors which influence drug disposition?
Demographic factors: Age, Weight, Genetics
Disease related: Liver disease, Renal Disease, Thyroid Disorders (hyper- and hypo-), Cardiovascular disease, GI disease, Cancer, Surgery, Burns, Nutritional State
Extracorporeal factors: Haemodialysis, Peritoneal dialysis, Cardiopulmonary bypass, Hypo- or hyperthermia
Chemical and environmental factors
- Absorption of drug (food or co-administered drug)
- Distribution of drug (competition for plasma proteins or tissue receptors).
- Metabolism of drug, food competes for metabolism or co-administered drug induces (phenobarbitone) or inhibits (ranitidine) metabolising enzyme.
- Excretion of drug, competes for excretory pathway (probenicid), alters urinary flow or may enhance tubular re-absorption (bicarbonate, phenobarbitone)
What is drug behavior defined by in compartmental methods?
Behaviour defined in terms of:
- Half-life (t1/2)
- Volume of distribution (VD)
- Clearance (CL)
- Bioavailability (F)
What is the definitions of the one compartmental model?
- The model assumes that drug is evenly distributed between all the tissues in the body – assumes absorption is instant, distribution is instant, and elimination is proportional (drug)
- Simply defined, the volume of distribution is the volume of plasma that would be necessary to account for the total amount of drug in the patient’s body, if that drug were present throughout the body at the same concentration as found in the plasma. This value is usually further divided by the patient’s body weight, and the result expressed in terms of litres per kilogram.
- If VD exceeds plasma volume, then would exceed the available volume for equal distribution (as in one compartment model). Therefore, drug must be concentrated in the tissues.
What is the Two Compartmental Model?
- Model does NOT treat tissues and plasma as behaving the same – more realistic but more complex
- The absorption phase usually ignored in practice and only the beta phase is used
How can sampling be conducted in the two compartmental model?
When to sample – when the distribution phase is over and the drug is mainly in the tissues where it is working – better correlation with effect e.g.
- Digoxin – sample 8hr post dose
- Lithium – sample 12hr post dose
Correlation with toxicity - paracetamol
What has to happen before sampling after a dose change?
When changing dose, time must be allowed before retesting otherwise therapeutic misadventure (e.g. phenytoin and digoxin).
What is the volume of distribution and halflife of drug poisoning?
- Salicylate: V0: 0.1-0.2l/kg, T1/2: 0.28hr
- Ethanol: V0: 0.5l/kg, T1/2: 2.1hr
- Theophylline: V0: 0.5-1.0l/kg, T1/2: 4hr
- Digoxin: V0: 10.0l/kg, T1/2: 40hr
- Amitriptyline: V0: 10.0l/kg, T1/2: 17-40hr
- Morphine: V0: 3.0-5.0l/kg, T1/2: 2-3hr
What are the sites of the metabolism of drugs?
Occurs in smooth ER of liver (microsomal fraction) with contribution from kidneys, lung and GI tract. Described as phase I or phase II reactions
What are the phases of metabolism?
Phase 1 Reactions: Expose suitable groups in drug for later conjugation via oxidation, reduction and hydrolysis reactions
Phase 2 Reactions: Addition of conjugates to increase water solubility
- Glucuronic acid
- Sulphate
- Amino acids (e.g. glycine)
- Glutathione
- Acetylation
Drug metabolite should now be polar enough for excretion.
What makes up the overall net effect renal elimination?
- Glomerular filtration
- Tubular secretion
- Tubular re-absorption (note effect of pH)
These processes are both active and passive.
What are the multiple factors that affect the rate of elimination in the kidney?
- Renal integrity
- Molecular Size
- Urine flow
- Urine pH
- Excretion of other compounds
Whya re drug not always elimnated in the kidneys?
- Generally, the route of excretion for drugs not excreted via kidney as they are Large (MW>300),Polar and Glucuronide conjugates
- Secretion into bile then intestines. Re-absorption can take place (entero-hepatic circulation) e.g. chloramphenicol.
- Ion trapping effect.
What are other excretion routes for Drug elimination?
- Saliva: not significant but has implications for drug screening and free drug measurement.
- Lungs: anaesthetic gases.
- Breast Milk: implications for nursing mothers, examples are: Lithium, Doxepin, Chemotherapeutics, Drugs of abuse
What is the definition fo Intestinal failure?
- A reduction in functioning gut mass below the minimal amount required for adequate digestion and absorption of fluid and/or electrolytes.’
- Loss or reduction of section(s) of the GIT causing malabsorption on a massive scale!
What are the principal underlying disease causes of intestinal failure?
- Short bowel
- Post-surgical complications – e.g. perforations
- Volvulus (twisting)
- Tumours of small intestine
- Motility disorders e.g. scleroderma
- Injury + trauma
- Congenital causes – born with short bowel. Hirschsprung disease – born without complete bowel nerve network
- Iatrogenic e.g. Bariatric obesity surgery